Skip to content
TrialMatch
Sign up
Recruiting

Positive Psychology for Early Cognitive Decline: Effects on Cognitive and Brain Function

Create a profile to match View the full record on ClinicalTrials.gov

About this study

This randomized study tests whether a new multicomponent Positive Psychology program can improve cognition and wellbeing in older adults at the earliest stages of dementia-related decline. About 128 participants with Subjective Cognitive Decline or Mild Cognitive Impairment will be enrolled. Half will be randomized to the Positive Psychology program and half to Treatment As Usual (TAU). The program consists of weekly, small-group online sessions for \~24 weeks plus brief home practices. All participants (both arms) will complete questionnaires and cognitive tests at baseline, during treatment, post-treatment, and 9-month follow-up. Primary question: Do participants receiving the Positive Psychology program show better cognitive and brain-function outcomes than TAU at post-treatment and at 9 months? Secondary question: Are effects larger for SCD than MCI? No medicines are used and risks are minimal. If effective, this scalable, low-cost, non-pharmacological approach could complement usual care for people in very early cognitive decline.

Condition
Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI), Alzheimer Dementia (AD)
Tested
Positive Psychology Intervention, Treatment as usual (TAU)
Sponsor
Aristotle University Of Thessaloniki

Who can join

Age
Not specified
Sex
All sexes
Healthy volunteers
Not accepted

Inclusion 2

  • Study condition: Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI), Alzheimer Dementia (AD)
  • Documented diagnosis of Subjective Cognitive Decline (SCD) or Mild Cognitive Impairment (MCI) according to clinical evaluation and site standard criteria.

Exclusion 5

  • Diagnosis of dementia (major neurocognitive disorder) or other major neurocognitive disorder that is moderate or severe.
  • Major psychiatric disorder currently unstable or untreated (e.g., major depression with psychotic features, bipolar disorder, schizophrenia).
  • Neurological conditions that affect cognition.
  • Uncorrected hearing or vision problems that prevent participation in assessments or online sessions.
  • Concurrent participation in another interventional study targeting cognition or wellbeing during the study period.

Where

1 site, 1 recruiting

Aristotle University of Thessaloniki

Thessaloniki, Greece

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.